Promethazine renders Escherichia coli susceptible to penicillin G: real-time measurement of bacterial susceptibility by fluoro-luminometry

International Journal of Antimicrobial Agents

Volumn 30, Issue 1, 2007, Pages 44-51

  Lehtinen, Janne ^a   Lilius, Esa Matti ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Antibiotic; Fluoro luminometry; Killing; Phenothiazine; Real time; Resistance; Susceptible; Viability

Indexed keywords

AMPICILLIN; PENICILLIN G; PROMETHAZINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; ESCHERICHIA COLI; FLUOROLUMINOMETRY; MEASUREMENT; MEMBRANE PERMEABILITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SPECTROSCOPY;

ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FLUOROMETRY; LUMINESCENT MEASUREMENTS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; PENICILLIN G; PERMEABILITY; PROMETHAZINE;

EID: 34249865621     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.02.019     Document Type: Article

References (46)

1. Csiszar K., and Molnar J. Mechanism of action of tricyclic drugs on Escherichia coli and Yersinia enterocolitica plasmid maintenance and replication. Anticancer Res 12 (1992) 2267-2272
2. Kristiansen J.E. The antimicrobial activity of non-antibiotics. Report from a congress on the antimicrobial effect of drugs other than antibiotics on bacteria, viruses, protozoa, and other organisms. APMIS Suppl. 30 (1992) 7-14
3. Labedan B. Increase in permeability of Escherichia coli outer membrane by local anesthetics and penetration of antibiotics. Antimicrob Agents Chemother 32 (1988) 153-155
4. Rajyaguru J.M., and Muszynski M.J. Enhancement of Burkholderia cepacia antimicrobial susceptibility by cationic compounds. J Antimicrob Chemother 40 (1997) 345-351
5. Wainwright M., Phoenix D.A., Laycock S.L., Wareing D.R., and Wright P.A. Photobactericidal activity of phenothiazinium dyes against methicillin-resistant strains of Staphylococcus aureus. FEMS Microbiol Lett 160 (1998) 177-181
6. Gutmann F., Johnson C., Keyzer H., and Molnár J. Charge transfer complexes in micro-organisms. Charge transfer complexes in biological systems (1997), Marcel Decker Inc., New York, NY 443-88
7. Molnar J., Hever A., Fakla I., Fischer J., Ocsovski I., and Aszalos A. Inhibition of the transport function of membrane proteins by some substituted phenothiazines in E. coli and multidrug resistant tumor cells. Anticancer Res 17 (1997) 481-486
8. Hendricks O., Butterworth T.S., and Kristiansen J.E. The in-vitro antimicrobial effect of non-antibiotics and putative inhibitors of efflux pumps on Pseudomonas aeruginosa and Staphylococcus aureus. Int J Antimicrob Agents 22 (2003) 262-264
9. Kristiansen M.M., Leandro C., Ordway D., et al. Phenothiazines alter resistance of methicillin-resistant strains of Staphylococcus aureus (MRSA) to oxacillin in vitro. Int J Antimicrob Agents 22 (2003) 250-253
10. Endicott J.A., and Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 58 (1989) 137-171
11. Rajyaguru J.M., and Muszynski M.J. Sensitization of Burkholderia cepacia to antibiotics by cationic drugs. J Antimicrob Chemother 41 (1998) 277-280
12. Heinrichs D.E., Yethon J.A., and Whitfield C. Molecular basis for structural diversity in the core regions of the lipopolysaccharides of Escherichia coli and Salmonella enterica. Mol Microbiol 30 (1998) 221-232
13. Whitfield C., Kaniuk N., and Frirdich E. Molecular insights into the assembly and diversity of the outer core oligosaccharide in lipopolysaccharides from Escherichia coli and Salmonella. J Endotoxin Res 9 (2003) 244-249
14. Nikaido H. Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria. Semin Cell Dev Biol 12 (2001) 215-223
15. Im W., and Roux B. Ions and counterions in a biological channel: a molecular dynamics simulation of OmpF porin from Escherichia coli in an explicit membrane with 1 M KCl aqueous salt solution. J Mol Biol 319 (2002) 1177-1197
16. Nikaido H. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 264 (1994) 382-388
17. Ananthan S., and Subha A. Cefoxitin resistance mediated by loss of a porin in clinical strains of Klebsiella pneumoniae and Escherichia coli. Indian J Med Microbiol 23 (2005) 20-23
18. Okusu H., Ma D., and Nikaido H. AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants. J Bacteriol 178 (1996) 306-308
19. Ma D., Cook D.N., Hearst J.E., and Nikaido H. Efflux pumps and drug resistance in gram-negative bacteria. Trends Microbiol 2 (1994) 489-493
20. Ma D., Cook D.N., Alberti M., Pon N.G., Nikaido H., and Hearst J.E. Molecular cloning and characterization of acrA and acrE genes of Escherichia coli. J Bacteriol 175 (1993) 6299-6313
21. Nathwani D., and Wood M.J. Penicillins. A current review of their clinical pharmacology and therapeutic use. Drugs 45 (1993) 866-894
22. Virta M., Karp M., and Vuorinen P. Nitric oxide donor-mediated killing of bioluminescent Escherichia coli. Antimicrob Agents Chemother 38 (1994) 2775-2779
23. Amsterdam D. Susceptibility testing of antimicrobials in liquid media. In: Lorian V. (Ed). Antibiotics in laboratory medicine. 4th ed. (1996), Lippincott, Williams and Wilkins, Baltimore, MD 52-111
24. Eliopoulos G.M., and Moellering R.C. Antimicrobial combinations. In: Lorian V. (Ed). Antibiotics in laboratory medicine. 3rd ed. (1991), Lippincott, Williams and Wilkins, Baltimore, MD 434-441
25. Lehtinen J., Jarvinen S., Virta M., and Lilius E.M. Real-time monitoring of antimicrobial activity with the multiparameter microplate assay. J Microbiol Methods 66 (2006) 381-389
26. Lehtinen J., Virta M., and Lilius E.M. Fluoro-luminometric real-time measurement of bacterial viability and killing. J Microbiol Methods 55 (2003) 173-186
27. Lehtinen J., Nuutila J., and Lilius E.M. Green fluorescent protein-propidium iodide (GFP-PI) based assay for flow cytometric measurement of bacterial viability. Cytometry A 60 (2004) 165-172
28. Tsien R.Y. The green fluorescent protein. Annu Rev Biochem 67 (1998) 509-544
29. Wilson T., and Hastings J.W. Bioluminescence. Annu Rev Cell Dev Biol 14 (1998) 197-230
30. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. M7-A6. Wayne, PA: NCCLS; 2003.
31. Gunics G., Motohashi N., Amaral L., Farkas S., and Molnar J. Interaction between antibiotics and non-conventional antibiotics on bacteria. Int J Antimicrob Agents 14 (2000) 239-242
32. Molnar J., Haszon I., Bodrogi T., Martonyi E., and Turi S. Synergistic effect of promethazine with gentamycin in frequently recurring pyelonephritis. Int Urol Nephrol 22 (1990) 405-411
33. Molnar J., Batho N., Csik V., Chevalier J., and Cremieux A. Interaction between tricyclic psychopharmacons and some antibiotics. Acta Microbiol Immunol Hung 42 (1995) 277-285
34. Eckert G.M., Gutmann F., and Keyzer H. Thiazine, antibiotic, bilirubin adducts. Xenobiotica 19 (1989) 567-579
35. Van Bambeke F., Balzi E., and Tulkens P.M. Antibiotic efflux pumps. Biochem Pharmacol 60 (2000) 457-470
36. Hansen L.H., Johannesen E., Burmolle M., Sorensen A.H., and Sorensen S.J. Plasmid-encoded multidrug efflux pump conferring resistance to olaquindox in Escherichia coli. Antimicrob Agents Chemother 48 (2004) 3332-3337
37. Kern W.V., Steinke P., Schumacher A., Schuster S., von Baum H., and Bohnert J.A. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli. J Antimicrob Chemother 57 (2006) 339-343
38. Nikaido H. The role of outer membrane and efflux pumps in the resistance of gram-negative bacteria. Can we improve drug access?. Drug Resist Updat 1 (1998) 93-98
39. Vaara M. Agents that increase the permeability of the outer membrane. Microbiol Rev 56 (1992) 395-411
40. Jenssen H., Hamill P., and Hancock R.E. Peptide antimicrobial agents. Clin Microbiol Rev 19 (2006) 491-511
41. Guo L., Lim K.B., Poduje C.M., et al. Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell 95 (1998) 189-198
42. Pages J.M., Dimarcq J.L., Quenin S., and Hetru C. Thanatin activity on multidrug resistant clinical isolates of Enterobacter aerogenes and Klebsiella pneumoniae. Int J Antimicrob Agents 22 (2003) 265-269
43. Martins A., Couto I., Aagaard L., Viveiros M., Kristiansen J.E., and Amaral L. Prolonged exposure of methicillin-resistant Staphylococcus aureus (MRSA) COL strain to increasing concentrations of oxacillin results in a multidrug-resistant phenotype. Int J Antimicrob Agents 29 (2007) 302-305
44. Viveiros M., Jesus A., Brito M., et al. Inducement and reversal of tetracycline resistance in Escherichia coli K-12 and expression of proton gradient-dependent multidrug efflux pump genes. Antimicrob Agents Chemother 49 (2005) 3578-3582
45. Amaral L, Engi H, Viveiros M, Molnar J. Comparison of multi-drug resistant efflux pumps of cancer and bacterial cells with respect to the same inhibitory agents. In Vivo 2007; in press.
46. Amaral L, Martins M, Viveiros M. Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps. J Antimicrob Chemother 2007, doi:10.1093/jac/dk1500, in press.